首页> 外文期刊>Pathogens and global health >Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India
【24h】

Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India

机译:在南印度三级护理中心通过个人捐赠核酸检测检测献血者中隐匿性乙型肝炎和窗口期感染

获取原文
获取原文并翻译 | 示例
           

摘要

With the introduction of highly sensitive hepatitis B surface antigen immunoassay, transfusion associated HBV infection have reduced drastically but they still tend to occur due to blood donors with occult hepatitis B infection (OBI) and window period (WP) infection. Sera from, 24338 healthy voluntary blood donors were screened for HBsAg, HIV and HCV antibody using Vitros Enhanced Chemiluminescent Immunoassay. The median age of the donor population was 30 (range 18-54) with male preponderance (98%). All serologically negative samples were screened by nucleic acid testing (NAT) for viral DNA and RNA. NAT-positive samples were subjected to discriminatory NAT for HBV, HCV, and HIV and all samples positive for HBV DNA were tested for anti-HBc, anti-HBs, HBeAg. Viral load was determined using artus HBV RG PCR Kit. Of the 24,338 donors screened, 99.81% (24292/24338) were HBsAg negative of which NAT was positive for HBV DNA in 0.0205% (5/24292) donors. Four NAT positive donors had viral load of <200 IU/ml making them true cases of OBI. One NAT positive donor was negative for all antibodies making it a case of WP infection. Among OBI donors, 75% (3/4) were immune and all were negative for HBeAg. Precise HBV viral load could not be determined in all (5/5) NAT positive donors due to viral loads below the detection limit of the artus HBV RG PCR Kit. The overall incidence of OBI and WP infections was found to be low at 1 in 6503 and 1 in 24214 donations, respectively. More studies are needed to determine the actual burden of WP infections in Indian blood donors.
机译:随着高度敏感的乙型肝炎表面抗原免疫测定技术的引入,与输血相关的HBV感染已大大减少,但由于献血者患有隐匿性乙型肝炎(OBI)和窗口期(WP)感染,它们仍倾向于发生。使用Vitros增强化学发光免疫测定法,从24338名健康自愿献血者的血清中筛选HBsAg,HIV和HCV抗体。供者群体的中位年龄为30岁(18-54岁),其中男性占优势(98%)。通过核酸测试(NAT)筛选所有血清学阴性样品的病毒DNA和RNA。对NAT阳性样品进行HBV,HCV和HIV的区分性NAT,并对所有HBV DNA阳性的样品进行抗HBc,抗HBs,HBeAg检测。使用artus HBV RG PCR Kit确定病毒载量。在筛选的24,338名供体中,有99.81%(24292/24338)的HBsAg阴性,其中NAT在0.025%(5/24292)的供体中为HBV DNA阳性。四个NAT阳性供体的病毒载量小于200 IU / ml,使其成为真正的OBI病例。一位NAT阳性供体对所有抗体均为阴性,使其成为WP感染病例。在OBI供体中,75%(3/4)是免疫性的,并且均为HBeAg阴性。由于病毒载量低于动脉HBV RG PCR试剂盒的检出限,因此无法在所有(5/5)NAT阳性供体中确定精确的HBV病毒载量。发现OBI和WP感染的总发生率分别很低,分别为6503例中的1例和24214例中的1例。需要更多的研究来确定印度献血者中WP感染的实际负担。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号